National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

PHA-739358
A small-molecule 3-aminopyrazole derivative with potential antineoplastic activity. Aurora kinase inhibitor PHA-739358 binds to and inhibits the Aurora kinases, which may result in cell growth arrest and apoptosis in tumor cells in which Aurora kinases are overexpressed. This agent may preferentially bind to and inhibit Aurora B kinase. Aurora kinases, a family of serine-threonine kinases, are important regulators of cellular proliferation and division. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:Aurora kinase inhibitor PHA-739358



Previous:pertuzumab, petrolatum-mineral oil-lanolin-ceresin ointment, PF-00299804, PGG beta-glucan, PGLA/PEG copolymer-based paclitaxel
Next:PHC, Phenergan, phenobarbital, phenoxodiol, phentolamine mesylate

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov